Initiating antiretroviral therapy within the first year of infection improved immune reconstitution and function in a U.S. military cohort.
Although most HIV-infected patients receiving antiretroviral therapy (ART) achieve an undetectable viral load, many do not attain a normal CD4-cell count. To assess how timing of ART initiation affects CD4-cell recovery, investigators evaluated immune reconstitution in 1199 HIV-infected U.S. Military HIV Natural History Study participants who had achieved an undetectable viral load (median pre-ART CD4-cell count, 358 cells/mm3). CD4-cell normalization was defined as achieving a count of >900 cells/mm3 (based on values from HIV-uninfected persons).
After virologic suppression for a median of 4.7 years, only 31% of participants achieved CD4-cell normalization. Normalization was significantly more common in patients who had initiated ART within…
Reviewing Author
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)